RTOG Foundation Master Service Agreement for Participation in Foundation Research: RTOG 3501 Tryhard: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb) for Non-HPV Locally Advanced Head and Neck Cancer with Concurrent Chemoradiation

Grant

Date/time Interval

  • October 1, 2012 - June 30, 2022
  • Total Award Amount

  • 36400.00
  • Direct Costs

  • 28889.00
  • Sponsor Award Id

  • Contributor

  • Christopher Willey M.D., Ph.D.   Investigator  
  • Eddy Yang M.D., Ph.D.   Investigator  
  • Jennifer De Los Santos   Principal Investigator  
  • John Fiveash M.D.   Investigator  
  • Kimberly Keene M.D.   Investigator  
  • Michael Dobelbower M.D.   Investigator  
  • Robert Kim M.D.   Investigator  
  • Rojymon Jacob M.D.   Investigator  
  • Ruby Meredith   Investigator  
  • Sharon Spencer M.D.   Investigator